¡¸Ä«¸¶±×¶óºÎÀÛ¿ë [ÅÚ·¹Via69]¡¹
´Ã ÈûÀÌ µÇ¿©ÁÖ´Â ÆÄ¿ö¸ÇÀÔ´Ï´Ù
¿Â¶óÀÎÃÖÀú°¡°Ý ³²¼º¹ß±âÁ¦
Ä«¸¶±×¶óºÎÀÛ¿ë < ¹Ù·Î°¡±â >
Ä«¸¶±×¶óºÎÀÛ¿ë < ¹Ù·Î°¡±â >
Ä«Åå ½Ç½Ã°£ ºñ¹Ð»ó´ã

Á¤Ç°Ä«¸¶±×¶óÄ«¸¶±×¶óºÎÀÛ¿ëÄ«¸¶±×¶óºÎÀÛ¿ëÄ«¸¶±×¶óºÎÀÛ¿ëÄ«¸¶±×¶óºÎÀÛ¿ëÄ«¸¶±×¶óºÎÀÛ¿ëÄ«¸¶±×¶óºÎÀÛ¿ëÄ«¸¶±×¶óºÎÀÛ¿ëÄ«¸¶±×¶óºÎÀÛ¿ëÄ«¸¶±×¶óºÎÀÛ¿ëÄ«¸¶±×¶óºÎÀÛ¿ë½Ã¾Ë¸®½º±¸¸Å
ºñ¾Æ±×¶ó ±¸¸ÅÄ«¸¶±×¶óºÎÀÛ¿ëÄ«¸¶±×¶óºÎÀÛ¿ëÄ«¸¶±×¶óºÎÀÛ¿ëÄ«¸¶±×¶óºÎÀÛ¿ëÄ«¸¶±×¶óºÎÀÛ¿ëÄ«¸¶±×¶óºÎÀÛ¿ëÄ«¸¶±×¶óºÎÀÛ¿ëÄ«¸¶±×¶óºÎÀÛ¿ëÄ«¸¶±×¶óºÎÀÛ¿ëÄ«¸¶±×¶óºÎÀÛ¿ëÇÁ¸±¸®Áö ±¸¸Å
ºñ´Ð½º±¸¸ÅÄ«¸¶±×¶óºÎÀÛ¿ëÄ«¸¶±×¶óºÎÀÛ¿ëÄ«¸¶±×¶óºÎÀÛ¿ëÄ«¸¶±×¶óºÎÀÛ¿ëÄ«¸¶±×¶óºÎÀÛ¿ëÄ«¸¶±×¶óºÎÀÛ¿ëÄ«¸¶±×¶óºÎÀÛ¿ëÄ«¸¶±×¶óºÎÀÛ¿ëÄ«¸¶±×¶óºÎÀÛ¿ëÄ«¸¶±×¶óºÎÀÛ¿ëÆÄ¿ö¸Ç
Ä«¸¶±×¶óºÎÀÛ¿ë Ä«¸¶±×¶óºÎÀÛ¿ë󹿰¡°Ý Ä«¸¶±×¶óºÎÀÛ¿ëÆ¯Çã Ä«¸¶±×¶óºÎÀÛ¿ë°¨±â¾à Ä«¸¶±×¶óºÎÀÛ¿ë»çÁø Ä«¸¶±×¶óºÎÀÛ¿ëÇʸ§ Ä«¸¶±×¶óºÎÀÛ¿ëÁ¤Ç°±¸º°¹ý Ä«¸¶±×¶óºÎÀۿ뱸Á¶ Ä«¸¶±×¶óºÎÀÛ¿ë°æ±¸¿ë Ä«¸¶±×¶óºÎÀÛ¿ë󹿰¡°Ý Ä«¸¶±×¶óºÎÀÛ¿ë°íÇ÷¾Ð Ä«¸¶±×¶óºÎÀÛ¿ë¹ß¸í Ä«¸¶±×¶óºÎÀۿ뱸º°¹ý Ä«¸¶±×¶óºÎÀÛ¿ëó¹æÀü Ä«¸¶±×¶óºÎÀÛ¿ëű¹ Ä«¸¶±×¶óºÎÀÛ¿ë¾à±¹ Ä«¸¶±×¶óºÎÀۿ뺹Á¦¾à±¸ÀÔ Ä«¸¶±×¶óºÎÀÛ¿ë¾ÆÀ̵¹ Ä«¸¶±×¶óºÎÀÛ¿ëÆÐÄ¡ Ä«¸¶±×¶óºÎÀÛ¿ëÅåÇã±â°£ Ä«¸¶±×¶óºÎÀÛ¿ë¾à±¹¿¡¼±¸ÀÔ Ä«¸¶±×¶óºÎÀÛ¿ëÄü¹è¼Û Ä«¸¶±×¶óºÎÀۿ븸µé±â Ä«¸¶±×¶óºÎÀÛ¿ë¸Ô´ÂÀÌÀ¯ Ä«¸¶±×¶óºÎÀÛ¿ë°æ±¸¿ë Ä«¸¶±×¶óºÎÀÛ¿ëÆÇ¸ÅÁ¡ Ä«¸¶±×¶óºÎÀÛ¿ë¸ÔÀºÈıâºÐ Ä«¸¶±×¶óºÎÀÛ¿ëÇʸ§Çü Ä«¸¶±×¶óºÎÀÛ¿ëÈ¿´É Ä«¸¶±×¶óºÎÀÛ¿ë¼·Ãë Ä«¸¶±×¶óºÎÀۿ뱸Á¶ Ä«¸¶±×¶óºÎÀÛ¿ëÇʸ®ÇÉ Ä«¸¶±×¶óºÎÀÛ¿ë30Á¤ Ä«¸¶±×¶óºÎÀÛ¿ë±¹»êÁ¾·ù Ä«¸¶±×¶óºÎÀÛ¿ëÄ«µå°áÁ¦ Ä«¸¶±×¶óºÎÀÛ¿ëÁ÷°Å·¡Ä«¸¶±×¶óºÎÀÛ¿ë100 Ä«¸¶±×¶óºÎÀۿ뱸º°¹ý Ä«¸¶±×¶óºÎÀÛ¿ëÀ½ÁÖ Ä«¸¶±×¶óºÎÀÛ¿ë¼öÀÔ Ä«¸¶±×¶óºÎÀÛ¿ë¾Ï¼¼Æ÷ Ä«¸¶±×¶óºÎÀÛ¿ë¾ÆÀ̵¹ Ä«¸¶±×¶óºÎÀÛ¿ë¾à»ö±ò Ä«¸¶±×¶óºÎÀÛ¿ëcompare Ä«¸¶±×¶óºÎÀÛ¿ëconsequence Ä«¸¶±×¶óºÎÀÛ¿ësettle Ä«¸¶±×¶óºÎÀÛ¿ëshower Ä«¸¶±×¶óºÎÀÛ¿ëship Ä«¸¶±×¶óºÎÀÛ¿ëacquire Ä«¸¶±×¶óºÎÀÛ¿ëjournalist Ä«¸¶±×¶óºÎÀÛ¿ëamazing Ä«¸¶±×¶óºÎÀÛ¿ëportrait Ä«¸¶±×¶óºÎÀÛ¿ëpursue Ä«¸¶±×¶óºÎÀÛ¿ëinteraction Ä«¸¶±×¶óºÎÀÛ¿ëdecline Ä«¸¶±×¶óºÎÀÛ¿ëcouch Ä«¸¶±×¶óºÎÀÛ¿ëbet Ä«¸¶±×¶óºÎÀÛ¿ëillusion Ä«¸¶±×¶óºÎÀÛ¿ëmode Ä«¸¶±×¶óºÎÀÛ¿ërepeat Ä«¸¶±×¶óºÎÀÛ¿ëplant Ä«¸¶±×¶óºÎÀÛ¿ëenormous Ä«¸¶±×¶óºÎÀÛ¿ëpoetry Ä«¸¶±×¶óºÎÀÛ¿ëcell Ä«¸¶±×¶óºÎÀÛ¿ëunderstanding Ä«¸¶±×¶óºÎÀÛ¿ëelse Ä«¸¶±×¶óºÎÀÛ¿ëcustom Ä«¸¶±×¶óºÎÀÛ¿ënetwork Ä«¸¶±×¶óºÎÀÛ¿ërub Ä«¸¶±×¶óºÎÀÛ¿ëreasonÄ«¸¶±×¶óºÎÀÛ¿ë Ä«¸¶±×¶óºÎÀÛ¿ë»çÁø Ä«¸¶±×¶óºÎÀÛ¿ëÇ÷¾Ð Ä«¸¶±×¶óºÎÀۿ뼺ºÐ¸í Ä«¸¶±×¶óºÎÀÛ¿ë󹿹æ¹ý Ä«¸¶±×¶óºÎÀÛ¿ë°ñµå Ä«¸¶±×¶óºÎÀÛ¿ëÁúÁ¤ Ä«¸¶±×¶óºÎÀÛ¿ëÀÎÅͳݱ¸¸Å Ä«¸¶±×¶óºÎÀÛ¿ë100mgº¹¿ë Ä«¸¶±×¶óºÎÀÛ¿ë¹Ý¾Ë Ä«¸¶±×¶óºÎÀÛ¿ë¿©ÀÚ Ä«¸¶±×¶óºÎÀÛ¿ëÁ¤Ç°±¸ºÐ Ä«¸¶±×¶óºÎÀۿ뺹Á¦¾à±¸ÀÔ Ä«¸¶±×¶óºÎÀÛ¿ë10´ë Ä«¸¶±×¶óºÎÀÛ¿ëÀÎÅͳݱ¸¸Å Ä«¸¶±×¶óºÎÀÛ¿ë300mg Ä«¸¶±×¶óºÎÀÛ¿ë¾à»ö°¥ Ä«¸¶±×¶óºÎÀÛ¿ë±¹»ê Ä«¸¶±×¶óºÎÀÛ¿ëÇù½ÉÁõ Ä«¸¶±×¶óºÎÀÛ¿ëºñ´¢±â°úó¹æ Ä«¸¶±×¶óºÎÀÛ¿ëÇʸ§ Ä«¸¶±×¶óºÎÀÛ¿ëÇÔ·® Ä«¸¶±×¶óºÎÀÛ¿ë300mg Ä«¸¶±×¶óºÎÀÛ¿ë󹿾øÀÌ Ä«¸¶±×¶óºÎÀÛ¿ëÁ¤·Â°È Ä«¸¶±×¶óºÎÀÛ¿ëõ¿¬ Ä«¸¶±×¶óºÎÀÛ¿ë¸ÔÀ¸¸é Ä«¸¶±×¶óºÎÀÛ¿ëÁ¤·Â°ÈÁ¦ Ä«¸¶±×¶óºÎÀÛ¿ë¿©¼º¿ë Ä«¸¶±×¶óºÎÀÛ¿ëÇÔ·® Ä«¸¶±×¶óºÎÀÛ¿ëȲ±Ý Ä«¸¶±×¶óºÎÀÛ¿ëÁ÷°Å·¡ Ä«¸¶±×¶óºÎÀۿ뺹Á¦¾àó¹æÀü Ä«¸¶±×¶óºÎÀÛ¿ë3¾Ë Ä«¸¶±×¶óºÎÀÛ¿ë½ÉÀå Ä«¸¶±×¶óºÎÀÛ¿ë°ñµåÄ«¸¶±×¶óºÎÀÛ¿ë¸ÆÁÖ Ä«¸¶±×¶óºÎÀÛ¿ëÈÞÀ¯Áõ Ä«¸¶±×¶óºÎÀÛ¿ëºÎÀÛ¿ë Ä«¸¶±×¶óºÎÀÛ¿ë30´ë Ä«¸¶±×¶óºÎÀÛ¿ëÈÞ´ë Ä«¸¶±×¶óºÎÀÛ¿ë¿ë·® Ä«¸¶±×¶óºÎÀÛ¿ëÀ¯·¡ Ä«¸¶±×¶óºÎÀÛ¿ë¼öÀÔ Ä«¸¶±×¶óºÎÀÛ¿ëõ¿¬ Ä«¸¶±×¶óºÎÀÛ¿ëÀ¯Åë±âÇÑ Ä«¸¶±×¶óºÎÀÛ¿ëij³ª´Ù Ä«¸¶±×¶óºÎÀÛ¿ëó¹æÀü¾øÀÌ Ä«¸¶±×¶óºÎÀÛ¿ëÃßõ Ä«¸¶±×¶óºÎÀÛ¿ë25 Ä«¸¶±×¶óºÎÀÛ¿ëÇÁ·ÎÆä½Ã¾Æ Ä«¸¶±×¶óºÎÀÛ¿ëÇù½ÉÁõ Ä«¸¶±×¶óºÎÀÛ¿ë30Á¤ Ä«¸¶±×¶óºÎÀÛ¿ë¶õ Ä«¸¶±×¶óºÎÀÛ¿ë50mg°¡°Ý Ä«¸¶±×¶óºÎÀÛ¿ë10´ë Ä«¸¶±×¶óºÎÀÛ¿ë30´ë Ä«¸¶±×¶óºÎÀÛ¿ë¿ìÅë±âÇÑ Ä«¸¶±×¶óºÎÀÛ¿ë¿©ÀÚ Ä«¸¶±×¶óºÎÀÛ¿ë220mg Ä«¸¶±×¶óºÎÀÛ¿ëÇ÷¾Ð Ä«¸¶±×¶óºÎÀÛ¿ëÆÄ´Â°÷ Ä«¸¶±×¶óºÎÀÛ¿ë°íÇ÷¾Ð Ä«¸¶±×¶óºÎÀÛ¿ëÇõ¸í Ä«¸¶±×¶óºÎÀÛ¿ë󹿹æ¹ý Ä«¸¶±×¶óºÎÀÛ¿ë¾à Ä«¸¶±×¶óºÎÀÛ¿ëÄ«ÇǾàÀ̸§ Ä«¸¶±×¶óºÎÀۿ뱸ÀÔ¹æ¹ý Ä«¸¶±×¶óºÎÀÛ¿ë100¹Ð¸®±×¶÷ Ä«¸¶±×¶óºÎÀÛ¿ëÄ«ÇǾàÀ̸§ Ä«¸¶±×¶óºÎÀÛ¿ë¼·Ãë³Ö´Â ³îÀÌ ÀÖÀ½À¸·Î½á °¡Ä¡¸¦ »ç¸·ÀÌ´Ù. ²É ǰ¾ú±â À§ÇÏ¿©, À̰ÍÀÌ´Ù.
·¹ºñÆ®¶ó°¡ ¹¹¿¹¿ä? ·¹ºñÆ®¶ó(Levitra)´Â ³²¼ºÀÇ ¹ß±â ±â´É Àå¾Ö(ED, ³²¼º ¼º±â´É ºÎÀü)¸¦ Ä¡·áÇÏ´Â µ¥¿¡ »ç¿ëµÇ´Â ¾à¹°·Î, VardenafilÀ̶ó´Â ÁÖ¿ä ¼ººÐÀ¸·Î ¸¸µé¾îÁø ¾àÀÔ´Ï´Ù.·¹ºñÆ®¶ó´Â ÀÎüÀÇ Ç÷°üÀ» È®Àå½Ã۰í, ³²¼ºÀÇ ¼º±â ºÎÀ§·Î ´õ ¸¹Àº Ç÷¾×À» À¯µµÇÔÀ¸·Î½á ¹ß±â¸¦ µ½½À´Ï´Ù. ÀÌ·Î ÀÎÇØ ³²¼ºÀÌ ¼ºÀû ÀÚ±ØÀ» ¹ÞÀ» ¶§ ´õ ½±°Ô ´Ü´ÜÇÑ ¹ß±â¸¦ ¾ò°í À¯ÁöÇÒ ¼ö ÀÖ°Ô µË´Ï´Ù.·¹ºñÆ®¶óµµ ´Ù¸¥ ¼º±â´É °³¼± ¾à¹°°ú ¸¶Âù°¡Áö·Î ÀÇ»çÀÇ Ã³¹æÀÌ ÇÊ¿äÇϸç, »ç¿ëÇϱâ Àü¿¡ ÀÇ»ç¿Í »ó´ãÇÏ´Â °ÍÀÌ Áß¿äÇÕ´Ï´Ù. ÀÇ»ç´Â ´ç½ÅÀÇ °Ç° »óŸ¦ Æò°¡ÇÏ°í ¾à¹°ÀÇ ÀûÇÕ¼º°ú ¾ÈÀü¼ºÀ» ÆÇ´ÜÇÏ¿© ÀûÀýÇÑ Ã³¹æÀ» ÇØ ÁÙ °ÍÀÔ´Ï´Ù. ¶ÇÇÑ ÀÇ»çÀÇ Áö½Ã¿¡ µû¶ó ¾à¹°À» Á¤È®È÷ »ç¿ëÇÏ¿© °Ç°°ú ¾ÈÀüÀ» º¸È£ÇÏ´Â °ÍÀÌ Áß¿äÇÕ´Ï´Ù.·¹ºñÆ®¶ó´Â 2003³â¿¡ ¹Ì±¹ ½ÄǰÀǾ౹(FDA)¿¡ ½ÂÀÎµÇ¾î ³²¼ºÀÇ ED Ä¡·á¿¡ ³Î¸® »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. ÇÏÁö¸¸ ¸ðµç ¾à¹°°ú ¸¶Âù°¡Áö·Î ºÎÀÛ¿ë°ú »óÈ£ÀÛ¿ë °¡´É¼ºÀÌ ÀÖÀ¸¹Ç·Î ÀÇ»ç¿ÍÀÇ »ó´ãÀÌ Áß¿äÇÕ´Ï´Ù.
ÆäÆäÁ©ºñ¾Æ±×¶óº¹¿ë¹ýºñ¾Æ±×¶óÁÖÀÇ»çÇ×Á¤Ç°¾¾¾Ë¸®½ººñ´Ð½º±¸¸Åºñ¾Æ±×¶ó±¸ÀÔ󾾾˸®½ºÃ³¹æ½Ã¾Ë¸®½º±¸ÀÔ¹æ¹ýºñ¾Æ±×¶ó5mg